About NanoDimension
NanoDimension is a venture capital firm founded in 2002. It is primarily based out of Woodside, United States. As of Sep 2019, NanoDimension has invested in 19 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Enterprise Applications. Most recently it participated in the $***** Series C round of Amphivena Therapeutics Overall, NanoDimension portfolio has seen 1 unicorn, 3 IPOs and 4 acquisitions including key companies like View, Visby Medical and Twist Bioscience. A lot of funds co-invest with NanoDimension, with names like Flagship Pioneering sharing a substantial percentage of its portfolio. NanoDimension has team of 4 people including 1 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B, Series A & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
NanoDimension's List of Top Investments
NanoDimension has a portfolio of 19 companies, one of which is a Unicorn. Their most notable investments are in SQZBiotech and Selecta Biosciences.Their portfolio spans across United States and Switzerland. They have invested in Life Sciences, High Tech, Enterprise Applications and 11 other sectors, across stages such as Series B, Series A and 3 more. Here is the list of top investments by NanoDimension:_1587543918761.png?format=webp&height=120&width=120){kind=logo}
1. View
View is a provider of AI and app-based smart windows glasses for buildings. It offers windows that are built using a proprietary electrochromic coating that reduces glare and heat and improves the energy efficiency of buildings. It also provides an AI-powered app that enables monitoring and controlling of the windows from remote places. Its app is available for Android devices.
Key facts about View
- Founded Year: 2007
- Location: Milpitas (United States)
- Annual Revenue: $101M as on Dec 31, 2022
- Stage: Public
- Total Funding till date: $3.01B
- Employee Count: 423 as on Mar 31, 2026
- Investors: Union Grove Venture Partners, BlackRock and 23 Others
- Latest Funding Round: Post IPO, Oct 27, 2022, $*****
- Highlight: Public
Provider of at-home tests for sexually transmitted infections with telehealth. The company provides testing for common curable sexually transmitted infections. If the test is positive, connection to a third-party licensed provider for treatment is included. The test results are available within thirty minutes using PCR technology.
Key facts about Visby Medical
- Founded Year: 2010
- Location: San Jose (United States)
- Valuation: $*****
- Stage: Series F
- Total Funding till date: $386M
- Employee Count: 179 as on Mar 31, 2026
- Investors: ND Capital, Lightrock and 26 Others
- Latest Funding Round: Series F, Jun 18, 2025, $*****
- Highlight: Editors' Pick
Developer of a semiconductor-based DNA synthesis platform. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA which is used in diverse fields of medicine, agriculture, industrial chemicals and data storage. It offers synthetic genes, oligo pools, and NGS target enrichment to support research and innovation
Key facts about Twist Bioscience
- Founded Year: 2013
- Location: San Francisco (United States)
- Annual Revenue: £3.34M as on Sep 30, 2024
- Stage: Public
- Total Funding till date: $321M
- Employee Count: 1,262 as on Mar 31, 2026
- Investors: Fidelity Investments, Foresite Capital and 39 Others
- Latest Funding Round: Series F, Apr 02, 2018, $*****
- Highlight: Public
4. H55
Developer of electric propulsion and energy storage systems for aviation. The company engineers and certifies energy storage that is predictable and safe. It designs protection, monitoring, and mitigation at the cell level. The company's energy storage system is an agnostic platform. It powers next-generation aircraft and shortens certification cycles.
Key facts about H55
- Founded Year: 2015
- Location: Sion (Switzerland)
- Stage: Series C
- Total Funding till date: $147M
- Employee Count: 151 as on Mar 31, 2026
- Investors: ND Capital, ACE & Company and 7 Others
- Latest Funding Round: Series C, Jul 24, 2024, $*****
- Highlight: Editors' Pick
5. SQZBiotech
Developer of cell therapies to treat multiple diseases. The company uses proprietary Cell Squeeze technology to deliver multiple biological materials into many cell types to engineer for therapeutic applications. The company has developed a pipeline for Oncology, Autoimmune and Infectious diseases.
Key facts about SQZBiotech
- Founded Year: 2013
- Location: Boston (United States)
- Stage: Acquired
- Total Funding till date: $168M
- Employee Count: 117 as on Dec 31, 2022
- Investors: Temasek, Old Silver VC and 26 Others
- Latest Funding Round: Grant (prize money), Mar 21, 2022, $*****
- Highlight: Acquired
NanoDimension's Year-on-Year Investment Trends
NanoDimension has invested in 19 companies over the last 20 years, with an average of 1 new investment annually in the last 10 years. Its most recent first time investment was in Amphivena Therapeutics and most recent follow-on round was in Inscripta.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 0 | 0 | 0 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 |
2020 | 0 | 0 | 0 |
2019 | 1 | 1 | 2 |
2018 | 2 | 2 | 4 |
2017 | 2 | 1 | 3 |
NanoDimension's Investments by Stage
NanoDimension has made 8 investments in Series B stage with an average round size of $19.6M, 3 investments in Series A stage with an average round size of $11.1M, 1 investment in Seed stage, 1 investment in Series C stage with an average round size of $62M and 1 investment in Series D stage with an average round size of $30M.Stage of entry | No. of Investments |
|---|---|
Series B | 8 |
Series A | 3 |
Seed | 1 |
Series C | 1 |
Series D | 1 |
Note: We have considered here, only first round of investments
NanoDimension's Investments by Sector
NanoDimension has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Energy Tech, Environment Tech and Sustainability Tech. Notably, it has invested in 16 Tech companies, 15 Enterprise (B2B) companies, 5 Software companies and at least 4 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 7 |
High Tech | 5 |
Energy Tech | 3 |
Environment Tech | 3 |
Sustainability Tech | 3 |
Others | 13 |
Note: We have considered here, only first round of investments
NanoDimension's Investments by Geography
NanoDimension has made most investments in United States (13), followed by Switzerland where it has made 1 investment.Country | No. of Investments |
|---|---|
United States | 13 |
Switzerland | 1 |
Note: We have considered here, only first round of investments
NanoDimension's recent investments
NanoDimension has not made any investment in 2026 so far.Here are the most recent investments by NanoDimension:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Sep 24, 2019 | United States | Series C | 2998 | [+4] | |
Jan 04, 2019 | United States | Series C | 9788 | ||
Aug 08, 2018 | United States | Series C | 8935 | [+9] | |
Feb 20, 2018 | United States | Series A | 2277 | - | |
Feb 20, 2018 | Switzerland | Seed | 8266 | - |
Unicorns in NanoDimension's Portfolio
NanoDimension has 1 unicorn in its portfolio - Visby Medical. The most recent unicorn in their portfolio is Visby Medical which became a unicorn in 2022, 3 years before NanoDimension first invested in it.Here is a list of unicorns in NanoDimension's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
70 | Provider of at-home tests for sexually transmitted infections with telehealth | 2010 | San Jose | Series F | atovhdx |
IPOs and Publicly Listed companies in NanoDimension's Portfolio
3 of NanoDimension's portfolio companies have become public. View got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Oct 2020 and Twist Bioscience got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ) at marketcap of $70M.Here are NanoDimension's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Oct 20, 2020 | Dec 14, 2010 | Series B | 4287 | |
Oct 31, 2018 | - | - | 2025 | |
Jun 24, 2016 | Feb 25, 2009 | Series B | 6332 |
_1587543918761.png?devicePixelRatio=2&height=20&width=20){kind=logo}
Acquired companies in NanoDimension's Portfolio
4 companies from NanoDimension's portfolio have been acquired. The most recent acquisition was SQZBiotech in Feb 2024 by Stem Cell Technologies for $*****.Here are NanoDimension's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Feb 29, 2024 | Dec 01, 2016 | Series B | 8107 | |
Aug 10, 2023 | Jun 16, 2006 | Series A | 2003 | |
May 10, 2018 | May 28, 2014 | Series B | 2117 | |
Dec 17, 2009 | Mar 27, 2008 | Series B | 4599 |
Team profile of NanoDimension
NanoDimension has a team of 4 members including 1 Partner and 1 Principal located in United States and Russia. NanoDimension's team sits on the board of 1 company.Co-investors of NanoDimension
Over the past 20 years, 117 investors have co-invested in NanoDimension's portfolio companies. This includes funds and angels.
- Invested before NanoDimension: Polaris Partners, HHS and 19 others have invested in rounds before NanoDimension. There are 2 companies where Polaris Partners has invested before NanoDimension and 2 companies where HHS has invested before NanoDimension.
- Top Co-investors of NanoDimension: 22 investors entered a company along with NanoDimension. These include investors like Flagship Pioneering (2 companies).
- Invested after NanoDimension: A total of 74 investors have invested in NanoDimension's portfolio after their investments. Top Investors include ND Capital (3 companies), Rusnano (3 companies) and Google Ventures (2 companies).
Recent News related to NanoDimension
•
•
Icosavax accesses $51m in series A roundGlobal Corporate Venturing•Oct 04, 2019•Icosavax, Sanofi Ventures, Qiming, NanoDimension and 1 other
•
Univ. of Washington spinout Icosavax raises $51M to fight viruses with computer-designed vaccinesGeekWire•Oct 03, 2019•Icosavax, Qiming, Adams Street Partners, Sanofi Ventures and 1 other
•
Amphivena Therapeutics lands $62 mln Series CPE Hub•Sep 24, 2019•Amphivena Therapeutics, Qiming, NanoDimension, Clough Capital Partners and 5 others
•
Inscripta Receives Additional $20MVC News Daily•Apr 04, 2019•Inscripta, Venrock, Foresite Capital, Merieux Developement and 3 others
•
Inscripta adds $30M to series C to speed use of its gene editing toolsBioCentury•Dec 19, 2018•Inscripta, Merieux Equity Partners, Venrock, Foresite Capital and 3 others
•
SQZ Biotech Completes Oversubscribed $72 Million Series C FinancingPR Newswire•Aug 08, 2018•SQZBiotech, EverBlu Capital, Invus, Illumina Ventures and 8 others
•
Gene-editing startup Inscripta raises $55.5 millionReuters•Feb 28, 2018•Inscripta, Merieux Developement, Paladin Capital, Venrock and 5 others
•
•
